Sanofi and its specialty care global business unit, Sanofi Genzyme, have announced that the European Commission (EC) has granted marketing authorisation for Kevzara® (sarilumab) in combination [...]
The US Food and Drug Administration has approved Haegarda, the first C1 Esterase Inhibitor (Human) for subcutaneous (under the skin) administration to prevent Hereditary Angioedema (HAE) attacks [...]
Only about a third (37 per cent) of the public trust evidence from medical research, compared to approximately two-thirds (65 per cent) who trust the experiences of their friends and family, [...]
A new study shows that many physicians who treat patients with ‘penicillin allergy’ listed in their charts may not fully understand important facts about penicillin allergy. They may not be aware [...]
LEO Pharma has announced that the first patients have been dosed in a phase three clinical study of tralokinumab. Tralokinumab is an investigational human monoclonal antibody that specifically [...]
From 18th to 24th September, charity, Blood Pressure UK, will be running its award-winning flagship campaign, Know Your Numbers! Week – the UK’s largest blood pressure testing and awareness event [...]
For decades, aspirin has been widely used to reduce the risk of cardiovascular problems. Now, a team led by a University of Florida (UF) Health researcher has found that aspirin may provide [...]
An old pharmaceutical product may be a new treatment for obstructive sleep apnea, according to new research presented by University of Illinois at Chicago (UIC) and Northwestern University [...]
In drug development, the body can be something of a black box. We take medicine and observe the overall effects, but what happens inside the body largely remains a mystery. To help clear up this [...]
